| Subcutaneous nanotherapy repurposes the immunosuppressive mechanism of rapamycin to enhance allogeneic islet graft viability JA Burke, X Zhang, S Bobbala, MA Frey, C Bohorquez Fuentes, ... Nature nanotechnology 17 (3), 319-330, 2022 | 54 | 2022 |
| Clinical relevance of pre-existing and treatment-induced anti-poly (ethylene glycol) antibodies H Freire Haddad, JA Burke, EA Scott, GA Ameer Regenerative Engineering and Translational Medicine, 1-11, 2021 | 53 | 2021 |
| Expanding opportunities to engineer mucosal vaccination with biomaterials HF Haddad, EF Roe, JH Collier Biomaterials Science 11 (5), 1625-1647, 2023 | 8 | 2023 |
| Engaging natural antibody responses for the treatment of inflammatory bowel disease via phosphorylcholine-presenting nanofibres EJ Curvino, EF Roe, H Freire Haddad, AR Anderson, ME Woodruff, ... Nature Biomedical Engineering 8 (5), 628-649, 2024 | 4 | 2024 |
| Active immunotherapy for C5a-mediated inflammation using adjuvant-free self-assembled peptide nanofibers KM Hainline, HF Haddad, A Gilpin, EJ Curvino, S Varghese, JH Collier Acta Biomaterialia 179, 83-94, 2024 | 1 | 2024 |
| Anti-polyethylene glycol (PEG) antibody mouse model for rigorous assessment of PEG-based therapies EA Scott, GA Ameer, JA Burke, HF Haddad US Patent 11,890,353, 2024 | 1 | 2024 |
| Supramolecular Peptide Self-Assemblies Facilitate Oral Immunization EJ Curvino, ME Woodruff, EF Roe, H Freire Haddad, P Cordero Alvarado, ... ACS Biomaterials Science & Engineering 10 (5), 3041-3056, 2024 | | 2024 |
| Raising Mucosal and Systemic Immune Responses Against Complement Anaphylatoxins for Inflammatory Disease. HF Haddad, KM Hainline, EJ Curvino, JH Collier | | |
